Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

48North Cannabis Corp. V.NRTH


Primary Symbol: NCNNF

Healthcare Drug Manufacturers - Specialty & Generic
48North Cannabis Corp is a vertically integrated cannabis company. It is focused on the health and wellness market through cultivation and extraction, as well as the creation of authentic brands for consumer-friendly products. Its products are categorized into Bath, Intimacy, Flower, Pre-roll, topical, vapes, concentrates, and accessories. It has two geographical segments: Canada, which is the key revenue driver; and the United States.


OTCPK:NCNNF - Post by User

48North Cannabis Corp. > Valuation
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by formon Jan 06, 2019 6:34pm
30 Views
Post# 29192836

RE:RE:RE:RE:Valuation

RE:RE:RE:RE:Valuation10 is my target for 2019 but if US legalise, a lot of ratio can change like Price/sales ratio or EBITDA. Analysts change the ratio, not me, 1999 is my reference. Just hope analysts follow NRTH.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities